Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis
نویسندگان
چکیده
منابع مشابه
Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis (PsO). The treatment of PsA can be challenging and includes non-steroidal anti-inflammatory drugs, synthetic disease modifying antirheumatic drugs, and biologicals. One novel oral compound that has been recently established for the treatment of PsO and PsA is apremilast, a small molecule PDE4 inhibitor. The inhibit...
متن کاملApremilast (Otezla): A New Oral Treatment for Adults With Psoriasis and Psoriatic Arthritis.
Apremilast (Otezla): A new oral treatment for adults with psoriasis and psoriatic arthritis.
متن کاملClinical potential of apremilast in the treatment of psoriatic arthritis
Psoriatic arthritis (PsA) is a frequent chronic inflammatory disease characterized by joint and skin involvement, and by typical extra-articular manifestations. Although the pathogenesis of PsA is still under investigation, the available evidence suggests the importance of the patient's genetic background, microbial or environmental triggers, and an imbalance in the adaptive and acquired immune...
متن کاملNew developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast
Psoriasis is a chronic inflammatory skin disease, most commonly resulting in the occurrence of red and silver scaly plaques. About 30% of psoriasis sufferers develop psoriatic arthritis (PsA), a disorder that presents with additional joint inflammation and other clinical features. At present, the most effective treatment for moderate and severe psoriasis and PsA are biologics such as antitumor ...
متن کاملUstekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
Biologics have revolutionized the therapy of the psoriatic disease spectrum. These new classes of drugs also allow deeper insight into the pathogenesis of the disease and highlight the existence of distinct "molecular" disease subgroups as evidenced by the spectrum of clinical response seen. Molecules associated with both the interleukin (IL)-17 and interferon (IFN)γ pathways have important fun...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical Council
سال: 2018
ISSN: 2079-701X
DOI: 10.21518/2079-701x-2018-12-136-141